BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9128760)

  • 1. Topical application of a first porphycene dye for photodynamic therapy--penetration studies in human perilesional skin and basal cell carcinoma.
    Karrer S; Abels C; Szeimies RM; Bäumler W; Dellian M; Hohenleutner U; Goetz AE; Landthaler M
    Arch Dermatol Res; 1997 Feb; 289(3):132-7. PubMed ID: 9128760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 9-Acetoxy-2,7,12,17-tetrakis-(beta-methoxyethyl)-porphycene (ATMPn), a novel photosensitizer for photodynamic therapy: uptake kinetics and intracellular localization.
    Szeimies RM; Karrer S; Abels C; Steinbach P; Fickweiler S; Messmann H; Bäumler W; Landthaler M
    J Photochem Photobiol B; 1996 Jun; 34(1):67-72. PubMed ID: 8765661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of the tumor microcirculation by photodynamic therapy with a synthetic porphycene.
    Abels C; Szeimies RM; Steinbach P; Richert C; Goetz AE
    J Photochem Photobiol B; 1997 Oct; 40(3):305-12. PubMed ID: 9372621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of topical delivery of mono-L-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy.
    Wong TW; Aizawa K; Sheyhedin I; Wushur C; Kato H
    J Pharmacol Sci; 2003 Oct; 93(2):136-42. PubMed ID: 14578580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration potency of topical applied delta-aminolevulinic acid for photodynamic therapy of basal cell carcinoma.
    Szeimies RM; Sassy T; Landthaler M
    Photochem Photobiol; 1994 Jan; 59(1):73-6. PubMed ID: 8127943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photosensitization of human skin cell lines by ATMPn (9-acetoxy-2,7,12,17-tetrakis-(beta-methoxyethyl)-porphycene) in vitro: mechanism of action.
    Fickweiler S; Abels C; Karrer S; Bäumler W; Landthaler M; Hofstädter F; Szeimies RM
    J Photochem Photobiol B; 1999 Jan; 48(1):27-35. PubMed ID: 10205875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosedependent photodynamic effects of 9-acetoxy-2,7,12,17-tetrakis(\-methoxyethyl)-porphycene in vitro.
    Karrer S; Szeimies RM; Ebert A; Fickweiler S; Abels C; Bäumler W; Landthaler M
    Lasers Med Sci; 1997 Dec; 12(4):307-12. PubMed ID: 20803269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment.
    Martin A; Tope WD; Grevelink JM; Starr JC; Fewkes JL; Flotte TJ; Deutsch TF; Anderson RR
    Arch Dermatol Res; 1995; 287(7):665-74. PubMed ID: 8534131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.
    Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G
    J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
    Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
    Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate.
    Angell-Petersen E; Sørensen R; Warloe T; Soler AM; Moan J; Peng Q; Giercksky KE
    J Invest Dermatol; 2006 Feb; 126(2):265-71. PubMed ID: 16374471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of positive or negative charges in the passive and iontophoretic skin penetration of porphyrins used in photodynamic therapy.
    Gelfuso GM; Gratieri T; Souza JG; Thomazine JA; Lopez RF
    Eur J Pharm Biopharm; 2011 Feb; 77(2):249-56. PubMed ID: 21118720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid.
    Fritsch C; Lehmann P; Stahl W; Schulte KW; Blohm E; Lang K; Sies H; Ruzicka T
    Br J Cancer; 1999 Mar; 79(9-10):1603-8. PubMed ID: 10188913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment.
    Haedersdal M; Katsnelson J; Sakamoto FH; Farinelli WA; Doukas AG; Tam J; Anderson RR
    Lasers Surg Med; 2011 Sep; 43(8):804-13. PubMed ID: 21956628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracutaneous ALA photodynamic therapy: dose-dependent targeting of skin structures.
    Sakamoto FH; Doukas AG; Farinelli WA; Tannous Z; Su Y; Smith NA; Zurakowski D; Anderson RR
    Lasers Surg Med; 2011 Sep; 43(7):621-31. PubMed ID: 22057490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma.
    Peng Q; Warloe T; Moan J; Heyerdahl H; Steen HB; Nesland JM; Giercksky KE
    Photochem Photobiol; 1995 Nov; 62(5):906-13. PubMed ID: 8570730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
    Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
    Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical photodynamic therapy of murine non-melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: pharmacokinetics, tumor response and cosmetic outcomes.
    Kyriazi M; Alexandratou E; Yova D; Rallis M; Trebst T
    Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):87-94. PubMed ID: 18353089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolism.
    Fritsch C; Verwohlt B; Bolsen K; Ruzicka T; Goerz G
    Arch Dermatol Res; 1996 Aug; 288(9):517-21. PubMed ID: 8874745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
    Boiy A; Roelandts R; de Witte PA
    J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.